Ladies and gentlemen,

Please find enclosed two new papers dealing with PLT VASP/P2Y12 kit (7014) from BioCytex.

  • Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies. The RESPOND Study; Gurbel P.A.et al., Circulation 2010;121:1188-1199.

    In conclusion, this is the first study to demonstrate that ticagrelor therapy overcomes nonresponsiveness to and HPR during clopidogrel therapy.

  • Pharmacodynamics and Pharmacokinetics of Single Doses of Prasugrel 30 mg and Clopidogrel 300 mg in Healthy Chinese and White Volunteers: An Open-Label Trial; Small DS et al., Clin Ther. 2010;32:365-379 .

    Conclusion: In Chinese subjects, prasugrel 30 mg produced greater platelet inhibition and higher Pras-AM concentrations than did clopidogrel 300 mg. The pharmacodynamic results were consistent across LTA,the VN-P2Y12 assay, and the VASP phosphorylation assay.

MILAN ANALYTICA is the exclusive Swiss distributor for BioCytex products (monoclonal antibodies against CD markers and kits for platelet diagnosis).

Please do not hesitate to contact us for further information.

Thank you for your attention and best regards

Julia Hirtle
Sales and Marketing Manager Distribution

 
  MILAN ANALYTICA AG
Baslerstrasse 15
4310 Rheinfelden/Basel
Switzerland

fon +41 (0)61 845 99 88
fax +41 (0)61 845 99 87
e-mail: julia.hirtle@milananalytica.ch
www.milananalytica.ch

 
  MILAN ANALYTICA AG • 4310 Rheinfelden • Switzerland • phone 0041 61 845 99 88
  If you do not want to receive such information, please send an e-mail to response@milananalytica.ch.